Differences between COVID‐19 and suspected then confirmed SARS‐CoV‐2‐negative pneumonia: A retrospective study from a single center

• DOI: 10.1002/jmv.25810
• Publication Date: 2020-04-01T15:37:05Z
• Authors: Xinyi Chen; Yi Yang; Min Huang; Lili Liu; Xianxiang Zhang; Jing Xu; Shaoqing Geng; Bo Han; Jiangfeng Xiao; Yanyun Wan
• Keywords: Procalcitonin; Coronavirus; 2019-20 coronavirus outbreak; Single Center

Abstract Coronavirus disease 2019 (COVID‐19) broke out in Wuhan, Hubei, China December 2019. Tens thousands of people have been infected with the disease. Our aim was to distinguish severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐positive patients from SARS‐CoV‐2‐negative patients. We retrospectively compared data COVID‐19 those suspected and confirmed (control patients). There were 78 26 control patients, whose median ages significantly different ( P = .001). The percentage admitting exposure Wuhan obviously higher than that X 29.130; < Fever cough appeared more frequently routine blood workup parameters did not change much their mean counts normal range. 38.5% had procalcitonin (PCT) levels 0.5 ng/mL, which 22.636; .05), also likely decreased or urea creatinine 24.930, 8.480; .05).Younger age, fever, cough, slight changes parameters, important features discriminating Slightly increased, but far less PCT differentiated